AWARDDELIVERY ORDERSmall business
Delivery order 75F40124F19007ANDEAN CONSULTING SOLUTIONS INTERNATIONAL LLC
Overview
Award facts
- Net obligations
- $525.02K
- $525,017of $895.98K potential value
- Outlays (paid to date)
- $186.6K
- $186.6K paid of $525.02K obligated$186,599
- Period of performance
- Feb 20, 2024 to Feb 28, 2027
- Ends in 3 months
- Modifications
- 4
- Latest action Mar 2, 2026
- Contract type
- Delivery order
- PIID 75F40124F19007
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
TASK ORDER IS TO PROCURE FOREIGN LANGUAGE TRANSLATION, INTERPRETATION, AND TRANSCRIPTION SERVICES TO SUPPORT THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF COMPLIANCE (OC).
Dates and value
- Award date
- Signed on Feb 20, 2024
- Potential end of performance
- Feb 27, 2029
- Current value
- $525,017Base and exercised options
- Potential value (if all options are exercised)
- $895,981
- Parent contract vehicle
- 75F40123D00005 (IDC, single award) — 26 orders recorded under it
Obligations by fiscal year of action
- FY2026: $180,177
- FY2025: $175,057
- FY2024: $169,783
Total across 3 fiscal years: $525,017
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 2, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationWASHINGTON, DC
UEIUFBGLHQVHUN5
CAGE code6CGG8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyANDEAN CONSULTING SOLUTIONS INTERNATIONAL LLC
Business types and certifications
Self-certified small disadvantaged businessSBA 8(a) program participantFor-profit organizationLimited liability companyCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0002
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R499SUPPORT- PROFESSIONAL: OTHER (service)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Not reported
- Contract pricing
- Time and materialsY
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Feb 20, 2024Base obligation at award: $169,783
- Latest action
- Mar 2, 2026 — Supplemental agreement (within scope)Modification P00004
- Latest substantive action
- Mar 2, 2026 — Supplemental agreement (within scope)Modification P00004
- Actions by type
- Base award1
- Option exercised2
- Supplemental agreement (within scope)1
- Other administrative action1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and all options
- $185,482
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2024/2024-0600-000
- 075-2025/2025-0600-000
- 075-2026/2026-0600-000
- 075-X-0600-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression